USPTO serial 90259143
BITSPECIMEN
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- HACK, ANDREA R
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BITSPECIMEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William M. Bryner
William M. Bryner KILPATRICK TOWNSEND & STOCKTON LLP1001 WEST FOURTH STREETWINSTON-SALEM, NC 27101UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable Computer software for encryption of human biomedical research, genomic information, and bioinformatics; downloadable computer software for encryption of genomic information in the field of clinical trials and clinical trials data; downloadable software for enterprise block chain development and implementation, execution and management of secure data transactions, management of data escrow, and provisioning of shared and distributed clinical trial patient biospecimen records and transactions; downloadable software to record genomic information data to a blockchain or other ledger; downloadable computer software for collection, interpretation, evaluation, auditing, management, processing, tracking and viewing of data in the field of clinical trials; downloadable computer software for data mining, data query, data processing and data analysis; downloadable computer software for use in data mining and analysis, namely, for use in blockchain development and implementation, execution and management of secure data transactions, management of data escrow, and provisioning of shared and/or distributed human biomedical research, genomic information, bioinformatics and biospecimen transactions | ACTIVE | — |
| 035 | Informatics services, namely, data collection and recording genomic information in the field of clinical trials and clinical trials data for business purposes; database management services, namely, management of secure data transactions, management of data escrow, and provisioning of shared and distributed clinical trial patient biospecimen records and transactions, all for business purposes; Informatics services, namely, data collection and recording genomic information to a blockchain or other ledger, all for business purposes; business services, namely, collection of data, business analysis, business auditing, business management, and processing of data in the field of clinical trials, and all for business purposes; business data analysis in the field of clinical trials; database management, namely, management of secure data transactions, management of data escrow, and provisioning of shared and distributed human biomedical research, genomic information, bioinformatics and biospecimen transactions, all for business purposes | ACTIVE | — |
| 042 | Providing temporary use of non-downloadable software for encryption of human biomedical research, genomic information, and bioinformatics; providing temporary use of non-downloadable software for encryption of genomic information in the field of clinical trials and clinical trials data; providing temporary use of non-downloadable software for enterprise block chain development and implementation, execution and management of secure data transactions, management of data escrow, and provisioning of shared and distributed clinical trial patient biospecimen records and transactions; providing temporary use of non-downloadable software to record genomic information data to a blockchain or other ledger; providing temporary use of non-downloadable software for collection, interpretation, evaluation, auditing, management, processing, tracking and viewing of data in the field of clinical trials; providing temporary use of non-downloadable software for data mining, data query, data processing and data analysis; providing temporary use of non-downloadable computer software for use in data mining and data analysis, namely, for use in blockchain development and implementation, execution and management of secure data transactions, management of data escrow, and provisioning of shared and/or distributed human biomedical research, genomic information, bioinformatics and bio specimen transactions; data mining | ACTIVE | — |
| 044 | Data collection and recording genomic information in the field of clinical trials and clinical trials data for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Covance, Inc.
- Other trademarks owned by Covance, Inc.
- Other trademarks owned by LABCORP DRUG DEVELOPMENT INC.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BITSPECIMEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 7, 2022 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 25, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 25, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 21, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 26, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 26, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 6, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 21, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 18, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 17, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 17, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 17, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 17, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 17, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 17, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 3, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 20, 2020 | NWAP | NEW APPLICATION ENTERED | — |